ReviewOncoTargets and therapy2019

Critical factors in chimeric antigen receptor-modified T-cell (CAR-T) therapy for solid tumors.

Lingli Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.